Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Venbio Global Strategic Fund Iv, L.P.

10% Owner at Attovia Therapeutics, Inc. (ATTO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$302K
Total bought / sold$6.5M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 10SEC ATTOAttovia Therapeutics, Inc. Buy 382,3524,181,367 held (+10%) $17.00 $6.5M -4.6%
  • Buy

    10% Owner Venbio Global Strategic Fund Iv, L.P. bought $6.5M of ATTO at $17.00 — first open-market purchase in our records.